AKEBIA THERAPEUTICS INC's ticker is and the CUSIP is 00972D905. A total of 4 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $788,310 | +126.0% | 691,500 | +81.4% | 0.00% | +200.0% |
| Q2 2023 | $348,798 | +138.9% | 381,200 | +46.3% | 0.00% | 0.0% |
| Q1 2023 | $145,982 | +315.4% | 260,500 | +327.8% | 0.00% | – |
| Q4 2022 | $35,139 | -31.1% | 60,900 | -62.0% | 0.00% | – |
| Q3 2022 | $51,000 | +75.9% | 160,400 | +98.0% | 0.00% | – |
| Q2 2022 | $29,000 | -83.4% | 81,000 | -66.7% | 0.00% | – |
| Q1 2022 | $175,000 | -70.5% | 243,500 | -7.3% | 0.00% | – |
| Q4 2021 | $594,000 | +30.3% | 262,800 | +66.0% | 0.00% | – |
| Q3 2021 | $456,000 | +44.3% | 158,300 | +90.0% | 0.00% | – |
| Q2 2021 | $316,000 | -37.3% | 83,300 | -44.0% | 0.00% | -100.0% |
| Q1 2021 | $504,000 | -25.2% | 148,800 | -38.2% | 0.00% | 0.0% |
| Q4 2020 | $674,000 | -48.6% | 240,800 | -53.9% | 0.00% | -75.0% |
| Q3 2020 | $1,311,000 | -49.9% | 522,300 | +170.9% | 0.00% | -66.7% |
| Q2 2020 | $2,618,000 | +1004.6% | 192,800 | +516.0% | 0.01% | +500.0% |
| Q1 2020 | $237,000 | -52.2% | 31,300 | -60.1% | 0.00% | -33.3% |
| Q4 2019 | $496,000 | +24700.0% | 78,500 | +15600.0% | 0.00% | – |
| Q3 2019 | $2,000 | -80.0% | 500 | -75.0% | 0.00% | – |
| Q2 2019 | $10,000 | -82.5% | 2,000 | -71.4% | 0.00% | -100.0% |
| Q1 2019 | $57,000 | -74.2% | 7,000 | -82.5% | 0.00% | -50.0% |
| Q4 2018 | $221,000 | +1478.6% | 39,900 | +2750.0% | 0.00% | – |
| Q2 2018 | $14,000 | -94.2% | 1,400 | -94.5% | 0.00% | -100.0% |
| Q1 2018 | $241,000 | +54.5% | 25,300 | +141.0% | 0.00% | +100.0% |
| Q4 2017 | $156,000 | +2500.0% | 10,500 | +3400.0% | 0.00% | – |
| Q3 2017 | $6,000 | -98.8% | 300 | -99.1% | 0.00% | -100.0% |
| Q2 2017 | $506,000 | +80.7% | 35,200 | +15.8% | 0.01% | +66.7% |
| Q1 2017 | $280,000 | +20.7% | 30,400 | +36.3% | 0.00% | +50.0% |
| Q4 2016 | $232,000 | +132.0% | 22,300 | +102.7% | 0.00% | +100.0% |
| Q3 2016 | $100,000 | -5.7% | 11,000 | -22.5% | 0.00% | 0.0% |
| Q2 2016 | $106,000 | -67.7% | 14,200 | -61.0% | 0.00% | -80.0% |
| Q1 2016 | $328,000 | +57.7% | 36,400 | +126.1% | 0.01% | +150.0% |
| Q4 2015 | $208,000 | -30.0% | 16,100 | -47.6% | 0.00% | -50.0% |
| Q3 2015 | $297,000 | +386.9% | 30,700 | +420.3% | 0.00% | +300.0% |
| Q2 2015 | $61,000 | 0.0% | 5,900 | +7.3% | 0.00% | 0.0% |
| Q1 2015 | $61,000 | +69.4% | 5,500 | +77.4% | 0.00% | 0.0% |
| Q4 2014 | $36,000 | -75.0% | 3,100 | -52.3% | 0.00% | -50.0% |
| Q3 2014 | $144,000 | – | 6,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 81,000 | $29,000 | 0.00% |
| SIMPLEX TRADING, LLC | 225,600 | $79,000 | 0.00% |
| JANE STREET GROUP, LLC | 47,300 | $17,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |